Capital Investment Support Connecting the orthopaedic industry with financial support from investment partners. ENQUIRE

Developing new products, expanding into new geographical regions and meeting regulatory requirements needs capital. For early stage businesses and SMEs, identifying the right finance partners and securing finance can be challenging. Using our connections and research specialists, we help companies identify suitable partners to help their transformation and drive growth.

Industry

 

There are many prolific investors. However, companies need to find the best ones that fit their ideology. Having an expert opinion and research can be invaluable for companies to save time and prevent mistakes. We build investor profiles to understand each firm’s typical investment criteria, the geographies, the sectors, the stage, and the size. We take time to understand investment firms’ strategies, typical deal structure, continued-support approach and length of term to identify the best option for our clients. There are many sector-agnostic investment firms; however, typically, these will not have a technical understanding of the medical device sector to appreciate the innovation within the industry unless they have a specialised division within the firm.

Investors

 

The medical device industry is highly regulated to ensure the safety and efficacy of technologies. This is a costly process that clients may need financial support with to become or maintain compliance. Being sector-specific, we know that young companies in the industry need capital for various stages across different phases of establishment, these include:

 

  • Expansion of geographical territory
  • Regulatory process compliance requirements (FDA, CE, MDR)
  • Research and development
  • Broadening commercialisation

Suzanna Everard

M&A and Investment Manager

 

Suzanna is the M&A, Investment and Research Manager. She delivers all transactional-based projects by supporting clients either sourcing investment or looking to undertake M&A activity for growth (buy-side) or final exit (sell-side).

Leading the in-house research team for all functions of the business producing bespoke reports and insight for the industry, Suzanna previously worked for an M&A sell-side advisory firm, supporting over 70 clients across multiple sectors.

Discover More

 

If you would like to speak to our team to discuss your strategy and the services we can provide, please get in touch.

Case Studies

BUY-SIDE M&A Case Study

Medical Device Manufacturer

 

To support our client with their inorganic growth strategy. We were engaged to deliver a pipeline of acquisition targets through identification, introduction and meeting facilitation.